Marie Cambot on Innovhem’s Quantification of The HbF/HbS Ratio for SCD
Marie Cambot, Co founder and CEO at INNOVHEM, reposted from INNOVHEM on LinkedIn:
”Many thanks to Dr. Anoosha Habibi for this important presentation and for using what we have developed at Innovhem, namely the quantification of the HbF/HbS ratio per cell, which allows us to provide the percentage of protected cells among the red blood cells of patients with sickle cell disease.”
Quoting INNOVHEM‘s post:
”We are delighted to share Dr. Anoosha Habibi’s work on the effect of iron deficiency on the efficacy of hydroxyurea treatment in sickle cell disease, presented at the ASH2025 conference!
These results highlight how our single-cell quantification of fetal hemoglobin can support therapeutic strategies and bring us closer to personalized care.
A big thank you to the entire team of UMGGR – GHU Henri Mondor, Pr Pablo Bartolucci MD PhD, Gonzalo De Luna, Vincent de Pierrefeu, Elena Properzi, Fatima Bensiradj, Geoffroy Volle, Anais Bourguignon d’Herbigny, Yosr Zaouali, Stephane Moutereau, Nicolas Hebert, Frédéric Galacteros and collaborators who made this possible.
Innovation in hematology is a collective effort, and we’re proud to contribute to advancing knowledge for better patient lives.
Curious to learn more?
Let’s connect and discuss how these results could impact future treatments.”
All from ASH25 featured in Hemostasis Today.
-
Dec 18, 2025, 17:13Daria Camilli on EuroBloodNet and EHC Collaboration for Bleeding Disorders
-
Dec 18, 2025, 16:26Yogesh Rathod on Hematological Issues and ICU
-
Dec 18, 2025, 16:09Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
-
Dec 18, 2025, 15:23Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals
-
Dec 18, 2025, 15:12Wolfgang Miesbach on Insights from Guy Young’s ASH2025 Session on Next-Generation Gene Therapy
-
Dec 18, 2025, 14:15Plasma-Derived Therapy for Hemophilia in The Updated European Medicines Agency’s Union List
-
Dec 18, 2025, 13:55Laurent Bertoletti: BAT-VTE is One of 7 Projects Funded Under the EFFECT Trial Call!
-
Dec 18, 2025, 13:34Alexandru Stieber Explores VEXAS Syndrome
-
Dec 18, 2025, 12:12Niraj Sharma: Can We Really Stop Anticoagulation After AF Ablation?